Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer.

scientific article

Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2018/9613185
P932PMC publication ID5977022
P698PubMed publication ID29887884

P50authorNaomi YoshuantariQ89056793
Susanna Hilda HutajuluQ89056795
Johan KurniandaQ89056796
Ahmad GhozaliQ89056797
P2093author name stringDidik Setyo Heriyanto
P2860cites workExpression of functional CXCR4 chemokine receptors on human colonic epithelial cellsQ24563114
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionQ24635943
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Q27861047
Cancer statistics, 2007Q29547293
Cancer statistics, 2016Q29547383
Chemokines: a new classification system and their role in immunityQ29615663
Optimization of the Isolation and Amplification of RNA From Formalin-fixed, Paraffin-embedded Tissue: The Armed Forces Institute of Pathology Experience and Literature ReviewQ33720473
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinomaQ33775283
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerQ33913953
Effector memory T cells, early metastasis, and survival in colorectal cancerQ33992461
CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasisQ34151630
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesionQ35875566
Role of chemokines in tumor growthQ36120825
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentQ36306137
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.Q36324953
Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancerQ36667494
Minimally invasive biomarkers for detection and staging of colorectal cancerQ36726838
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.Q37684176
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patientsQ37685449
Metastatic colorectal cancer: from improved survival to potential cureQ37762682
The expression and role of CXC chemokines in colorectal cancer.Q37946029
A review on CXCR4/CXCL12 axis in oncology: no place to hide.Q38017493
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trialQ38661133
Targeting SDF-1 in multiple myeloma tumor microenvironmentQ38666014
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy.Q39333110
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapyQ39337489
Occult anterograde flow is an under-recognized but crucial predictor of early recanalization with intravenous tissue-type plasminogen activator.Q40258410
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patientsQ40283597
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activationQ40381071
CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancerQ41041246
The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.Q41614934
Chemokine receptor expression by human intestinal epithelial cellsQ41681584
Will the Stroma-derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer?Q42592787
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathwayQ44078163
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancerQ45870196
Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response CriteriaQ47378801
The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.Q50854225
Response to Letter Regarding Article,"Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies".Q52986560
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.Q53383475
CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer.Q54228829
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.Q54669043
Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected miceQ71829474
Differential CXC receptor expression in colorectal carcinomasQ79719780
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancerQ80643044
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progressionQ83187267
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatmentQ84424082
Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignanciesQ85075420
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectcolorectal cancerQ188874
P304page(s)9613185
P577publication date2018-05-16
P1433published inGastroenterology research and practiceQ26853898
P1476titleClinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer
P478volume2018

Search more.